Long Beach

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Schizophrenia2 trials
• Alzheimer disease1 trial
• Macular degeneration1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• MapLight Therapeutics2 trials
• Outlook Therapeutics, Inc.1 trial

Running trials

• Recruiting

  A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

  NCT07459647· Phase 2· MapLight Therapeutics· Source

• Recruiting

  A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

  NCT06887192· Phase 2· MapLight Therapeutics· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Schizophrenia2 recruiting
• Alzheimer disease1 recruiting

Closed trials

• Completed

  A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

  NCT06190093· Phase 3· Outlook Therapeutics, Inc.· Source